Skip to content
Open access

Periprosthetic Femoral Fracture in Hip Arthroplasty Using Cemented Stems: Toward a Construct-Level and Time-Dependent Perspective

Oct 2026 · Bioengineering · 0 citations · 42 references

Abstract

Periprosthetic femoral fracture (PFF) is an increasingly recognized complication following cemented total hip arthroplasty (THA); it is associated with substantial morbidity and mortality and often occurring several years after implantation. Although polished taper-slip (PTS) stems demonstrate favorable long-term survivorship, they have also been associated with a higher incidence of PFF, the biomechanical basis of which remains unclear. Existing studies have investigated a few key aspects of cemented THA, including implant migration, cement behavior, and fracture biomechanics. However, these factors are typically examined in isolation or under simplified conditions, and current construct-level models evaluate fracture without accounting for prior loading history. Pre-clinical testing standards relevant to fracture in cemented THA remain limited, with existing standards addressing individual components under simplified laboratory conditions rather than the integrated periprosthetic system under a physiologically relevant environment. As a result, how the implant–cement–bone construct evolves from implantation to eventual failure remains insufficiently characterized. In this study, we critically evaluate current experimental approaches and identify the absence of a time-resolved, construct-level framework as a key limitation. We outline a conceptual framework describing how implant migration, material response, and fracture behavior evolve with loading exposure. This framework may provide a foundation for both improving the mechanistic understanding of PFF and supporting the development of future pre-clinical testing strategies that can better reflect clinical loading conditions.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.